Japan Oncology NGS Market (2025-2031) | Analysis, Outlook, Trends, Growth, Share, Companies, Segmentation, Competitive Landscape, Size & Revenue, Industry, Value, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Japan Oncology NGS Market - Industry Life Cycle

3.4 Japan Oncology NGS Market - Porter's Five Forces

3.5 Japan Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Japan Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Japan Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F

3.8 Japan Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 Japan Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing prevalence of cancer in Japan

4.2.2 Technological advancements in next-generation sequencing (NGS) for oncology

4.2.3 Increasing investments in research and development for personalized medicine in oncology

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for NGS in oncology in Japan

4.3.2 High costs associated with NGS technologies and tests in oncology

6.1 Japan Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Japan Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Japan Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Japan Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2 Japan Oncology NGS Market, By Application

6.2.1 Overview and Analysis

6.2.2 Japan Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F

6.2.3 Japan Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F

6.3 Japan Oncology NGS Market, By Service

6.3.1 Overview and Analysis

6.3.2 Japan Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F

6.3.3 Japan Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F

6.4 Japan Oncology NGS Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 Japan Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.4.3 Japan Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.4.4 Japan Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.5 Japan Oncology NGS Market, By End-use

6.5.1 Overview and Analysis

6.5.2 Japan Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F

6.5.3 Japan Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F

6.5.4 Japan Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.5.5 Japan Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F

6.5.6 Japan Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F

7.1 Japan Oncology NGS Market Export to Major Countries

7.2 Japan Oncology NGS Market Imports from Major Countries

8.1 Average turnaround time for NGS testing in oncology

8.2 Number of clinical trials utilizing NGS in oncology in Japan

8.3 Adoption rate of NGS-based treatment protocols in oncology

9.1 Japan Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Japan Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Japan Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F

9.4 Japan Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 Japan Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Japan Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Japan Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters